Rotator Cuff Injury
Conditions
Interventions
A:0.25% Ropivacaine 10ml+0.9% normal saline (1ml)
B:0.5% Ropivacaine 10ml+0.9% normal saline (1ml)
C:0.75% Ropivacaine 10ml+0.9% normal saline (1ml)
D:0.25% Ropivacaine 10ml+5mg dexamethasone (1ml)
E:0.5% Ropivacaine 10ml+5mg dexamethasone (1ml)
F:0.75% Ropivacaine 10ml+5mg dexamethasone (1ml)
Sponsors
Liaoning Provincial People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients aged 18-80 years who plan to undergo shoulder Arthroscopy surgery with ASA classification I-III
Exclusion criteria
Exclusion criteria: 1. Patients who refused to participate in this study; 2. Infection of the operating site and abnormal anatomy of the site; 3. Study the history of Drug allergy reaction; 4. Systemic use of Corticosteroid for two weeks or more; 5. Peripheral neuropathy, previous musculocutaneous, radial, and ulnar neuropathy; 6. Mental disorders, coagulation disorders; 7. BMI>35kg/m ²; 8. Serious pulmonary diseases (such as acute exacerbation of COPD), cardiac insufficiency (such as EF1.5 times the upper normal limit or GFR<40ml/min); 9. Pregnant or lactating women; 10. Patients who are chronically using opioid drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of sensory;Diastolic pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of motor block;Demand for analgesics within 24 hours after operation;Patient NRS pain score;The incidence of postoperative nausea and vomiting;Systolic pressure;Mean arterial pressure;Heart rate;Oxygen saturation;BIS; | — |
Countries
China
Contacts
Public ContactChangming Wang
Liaoning Provincial People's Hospital
Outcome results
None listed